| Brand Name | Velsipity |
| Generic Name | Etrasimod |
| Drug Class | Monoclonal Antibody (Anti-TL1A) |
| Availability | Prescription |
| Manufacturer | Arena Pharmaceuticals (Pfizer) |
| Indications | Ulcerative Colitis, Crohn's Disease |
| Type | Tablet |
| Doses | 2 mg daily for maintenance |
| Route | Oral |
| Side Effects | Headache, constipation, fatigue |
| Interactions | Immunomodulator; avoid live vaccines; increased infection risk |
| Overdose | Limited data; monitor for infection, headache. |
| Missed Dose | Inject ASAP; resume schedule. |
| Contraindications | Severe hepatic impairment, active infection |
| Alternatives | Tofacitinib, Vedolizumab |
| Co-Pay Assistance Program | Available Rx |
| Patient Assistance Program | Not available |
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
Etrasimod is used to treat moderate to severe ulcerative colitis and is being studied for other inflammatory diseases like Crohn's disease and multiple sclerosis.
Etrasimod works by targeting specific immune system receptors that control the movement of white blood cells, reducing inflammation in the intestines and other affected areas.
Common side effects include upper respiratory infections, headache, diarrhea, and elevated liver enzymes. Serious side effects may include heart problems.
Etrasimod is still being studied for its effectiveness in treating multiple sclerosis, but early clinical trials show promise in reducing disease activity.
Etrasimod is typically taken as an oral tablet once daily. The dosage and frequency will be prescribed by your healthcare provider based on your condition.
Etrasimod is being researched for its potential use in treating Crohn's disease, with some early studies showing it may help control inflammation in the digestive tract.
Consult your doctor before using Etrasimod during pregnancy. Its safety during pregnancy has not been fully established, so it should only be used if necessary.
Etrasimod may interact with other medications, especially those that affect the immune system. Always inform your healthcare provider of all medications you're taking.
If you miss a dose of Etrasimod, take it as soon as you remember unless it�s almost time for the next dose. Do not take two doses at once.
It may take several weeks to notice the full effects of Etrasimod, especially in treating inflammatory conditions like ulcerative colitis.
Related Conditions |
Related Blogs |
|---|---|
